OptiNose, Inc. (NASDAQ:OPTN – Get Rating) CEO Peter K. Miller sold 48,225 shares of the firm’s stock in a transaction dated Friday, September 16th. The shares were sold at an average price of $3.55, for a total value of $171,198.75. Following the completion of the transaction, the chief executive officer now owns 892,677 shares in the company, valued at approximately $3,169,003.35. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
OptiNose Trading Down 2.4 %
NASDAQ:OPTN opened at $3.67 on Friday. OptiNose, Inc. has a 1-year low of $1.46 and a 1-year high of $4.30. The business’s 50-day moving average price is $3.66 and its two-hundred day moving average price is $2.96. The firm has a market capitalization of $305.63 million, a price-to-earnings ratio of -3.37 and a beta of -0.08.
OptiNose (NASDAQ:OPTN – Get Rating) last released its earnings results on Thursday, August 11th. The company reported ($0.23) earnings per share for the quarter, missing the consensus estimate of ($0.22) by ($0.01). The business had revenue of $20.58 million during the quarter, compared to analysts’ expectations of $22.30 million. Sell-side analysts predict that OptiNose, Inc. will post -0.82 earnings per share for the current year.
Hedge Funds Weigh In On OptiNose
OptiNose, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device.
- Get a free copy of the StockNews.com research report on OptiNose (OPTN)
- What Steelcase’s Earnings Say About the Return to the Office?
- The Institutions Hold On To Darden Restaurants International
- Is The Golden Age Of Homebuilding Already Over?
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
Receive News & Ratings for OptiNose Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiNose and related companies with MarketBeat.com's FREE daily email newsletter.